Collectively, these data indicate that TCR signalling in the TME can induce Rig-I upregulation in CD8+ T cells, which inhibits the AKT/glycolysis signalling pathway to negatively regulate the anti-tumour activity of CD8+ T cells. Here, AKT1 is linked to neoplasm.